Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Shire plc | dp42645_8k.htm |
Exhibit 99.01
|
Press Release
|
 |
|
www.shire.com
|
Block Listing Six Monthly Return
December 18, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG)
|
Name of applicant:
|
Shire plc
|
|||
|
Name of scheme:
|
2.75% Convertible Bonds due 2014
|
|||
|
Period of return:
|
From:
|
November 27, 2013
|
To:
|
December 18, 2013
|
|
Balance of unallotted securities under scheme(s) from previous return:
|
Nil
|
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
|
33,068,902
|
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
|
33,039,624
|
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
|
29,278
|
|||
The remaining 29,278 securities relating to the Shire plc 2.75% Convertible Bonds due 2014 have lapsed and these shares have therefore been cancelled.
|
Name of contact:
|
Tony Guthrie, Deputy Company Secretary
|
|
Address of contact:
|
Hampshire International Business Park
Basingstoke, Hampshire, RG24 8EP
|
|
Telephone number of contact:
|
01256 894746
|
For further information please contact:
|
Investor Relations
|
||
|
Eric Rojas
|
erojas@shire.com
|
+1 781 482 0999
|
|
Sarah Elton-Farr
|
seltonfarr@shire.com
|
+44 1256 894157
|
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.
www.shire.com
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX